A commercial breakthrough in the field of complex therapeutic proteins for dogs by sector leader Zoetis (ZTS.N) has roused rivals to action in a hunt for biotechnology medicines to treat pets.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,